Age (years) | Proteinuria | ||
---|---|---|---|
(−) | (±) | (+≤) | |
Men | |||
20–29 | 100.0 ± 16.9 | 98.3 ± 18.2 | 94.9 ± 15.6 |
30–39 | 90.4 ± 16.1 | 85.3 ± 17.5 | 84.4 ± 16.0 |
40–49 | 82.0 ± 15.2 | 81.1 ± 14.5 | 81.0 ± 18.9 |
50–59 | 77.7 ± 15.5 | 84.3 ± 19.7 | 76.9 ± 20.9 |
60–69 | 73.0 ± 15.1 | 75.9 ± 24.1 | 70.9 ± 16.3 |
70–79 | 69.1 ± 12.8 | 63.7 ± 24.7 | 61.2 ± 21.0 |
Total | 85.5 ± 18.4 | 85.3 ± 19.8 | 79.5 ± 19.9a,b |
Number of subjects with reduced eGFR (%) | 216 (6.9) | 16 (7.4) | 21 (15.0) |
Women | |||
20–29 | 107.3 ± 21.9 | 101.0 ± 20.9a | 94.1 ± 19.9a |
30–39 | 96.8 ± 20.2 | 98.1 ± 20.6 | 92.9 ± 21.2 |
40–49 | 88.0 ± 19.1 | 80.4 ± 15.6a | 85.6 ± 16.2 |
50–59 | 81.3 ± 18.7 | 77.9 ± 19.4 | 76.8 ± 18.6 |
60–69 | 75.8 ± 15.9 | 72.2 ± 22.2 | 62.5 ± 25.2a |
70–79 | 71.2 ± 16.5 | 64.8 ± 11.8 | 62.3 ± 8.3 |
Total | 91.4 ± 22.6 | 89.5 ± 22.7 | 83.8 ± 22.6a |
Number of subjects with reduced eGFR (%) | 374 (5.3) | 22 (7.0) | 21 (16.2) |